QuickView for Fibronectin type II domain (biogroup)

1. L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens

There were no matches for Fibronectin type II domain

1. Irisin Expression and Gene Polymorphism in Type II Diabetic Patients With and Without CAD
2. IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study
3. Injection of an Autologous A2M Concentrate Alleviates Back Pain in FAC-positive Patients
4. A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytoki…
5. Intratumoral Application of L19IL2 in Patients With Malignant Melanoma